Key result
A novel parechovirus-like virus (PLV-CHN) was identified in 20% of healthy piglets, and serological testing revealed a high seroprevalence of 63.5% in the healthy human population, suggesting early-life infection.
Cross-Sectional (n=1,102)
Yes
A novel parechovirus-like virus (PLV-CHN) was identified in healthy piglets, and while human viral shedding was not detected, high seroprevalence suggests it or a related virus commonly infects humans early in life.
Answers are grounded in this paper and cite their sources.
High seroprevalence suggests common early human exposure to parechovirus-like viruses; hypothesis-generating for zoonotic risk and needs prospective validation.
In this study, we describe a novel porcine parechovirus-like virus (tentatively named PLV-CHN) from healthy piglets in China using 454 high-throughput sequencing. The complete genome of the virus comprises 6832 bp, encoding a predicted polyprotein of 2132 amino acids that is most similar to Ljungan virus (32% identity). A similar virus that belongs to a novel Picornaviridae genus, named swine pasivirus 1 (SPaV-1), was reported during the preparation of this paper. Sequence analysis revealed that PLV-CHN and SPaV1 shared 82% nucleotide identity and 89% amino acid identity. Further genomic and phylogenetic analyses suggested that both SPaV1 and PLV-CHN shared similar genomic characteristics and belong to the same novel Picornaviridae genus. A total of 36 (20.0%) fecal samples from 180 healthy piglets were positive for PLV-CHN by RT-PCR, while no fecal samples from 100 healthy children and 100 children with diarrhea, and no cerebrospinal fluid samples from 196 children with suspected viral encephalitis, was positive for the virus. However, Western blot and enzyme-linked immunosorbent assays using recombinant PLV-CHN VP1 polypeptide as an antigen showed a high seroprevalence of 63.5% in the healthy population. When grouped by age, the antibody-positivity rates showed that the majority of children under 12 years of age have been infected by the virus. It was suggested that PLV-CHN, SPaV1, or an as-yet-uncharacterized virus can infect humans early in life. Thus, investigation of the role of this novel virus is vital.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2013) conducted a cross-sectional in Healthy and PLV-CHN infection (n=1,102). PLV-CHN (novel picornavirus) was evaluated on Seroprevalence of PLV-CHN antibodies in healthy humans. A novel parechovirus-like virus (PLV-CHN) was identified in 20% of healthy piglets, and serological testing revealed a high seroprevalence of 63.5% in the healthy human population, suggesting early-life infection.
Synapse has enriched 10 related papers. Consider them for comparative context: